Physician profile
Narinder Kumar
NPI 1245205269
$1,071.06
in general payments reported to CMS, 2019-2025
24 companies · $84.54 in 2025
The $84.54 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.30 · 2020: $58.18 · 2021: $321 · 2022: $102 · 2023: $266 · 2024: $198 · 2025: $84.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $244.81 | 2021-2024 | |
| Abbvie INC. | $197.37 | 2021-2024 | |
| Adlon Therapeutics L.P. | $84.41 | 2020-2021 | |
| Eisai INC. | $58.27 | 2024 | |
| Sanofi Pasteur INC. | $48.37 | 2023-2025 | |
| Pfizer INC. | $42.25 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $41.99 | 2023-2024 | Rexulti |
| Amarin Pharma, INC. | $34.55 | 2021 | |
| Corium, LLC | $33.76 | 2023 | Azstarys |
| Avanir Pharmaceuticals, INC. | $32.73 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.38 | 2024 | Trintellix |
| Neurocrine Biosciences, INC. | $22.71 | 2025 | |
| Seqirus USA INC | $21.62 | 2022 | |
| Nestle Healthcare Nutrition INC. | $21.25 | 2021 | |
| Collegium Pharmaceutical, INC. | $21.19 | 2025 | Jornay Pm |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $20.71 | 2021 | |
| Dexcom, INC. | $19.73 | 2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $16.11 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $15.71 | 2021 | |
| Phadia US INC. | $15.43 | 2023 | Immunocap |
| Inogen, INC. | $14.97 | 2022 | |
| Ironshore Pharmaceuticals INC. | $14.55 | 2020 | |
| Acadia Pharmaceuticals INC | $13.25 | 2019 | |
| Janssen Pharmaceuticals, INC | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narinder Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.